| scholarly article | Q13442814 |
| P50 | author | Bernard Zinman | Q61337175 |
| Anthony J Hanley | Q89837571 | ||
| P2093 | author name string | Vladimir Vuksan | |
| Ravi Retnakaran | |||
| Jill K Hamilton | |||
| Sandy Shen | |||
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| Statistical data analysis in the computer age. | Q31123302 | ||
| Dilution of the 75-g oral glucose tolerance test improves overall tolerability but not reproducibility in subjects with different body compositions | Q31879879 | ||
| The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus | Q33853759 | ||
| Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin | Q34335548 | ||
| Accurate assessment of beta-cell function: the hyperbolic correction | Q34508795 | ||
| The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes | Q34655580 | ||
| The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes | Q35085591 | ||
| Methods for clinical assessment of insulin sensitivity and beta-cell function | Q35214627 | ||
| Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies | Q35649213 | ||
| Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests | Q36753104 | ||
| Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose | Q37006231 | ||
| Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome | Q42522952 | ||
| Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times | Q43584254 | ||
| Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. | Q44043219 | ||
| Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects | Q44185351 | ||
| Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients | Q44526998 | ||
| Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents | Q44786939 | ||
| Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study | Q44956971 | ||
| Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications | Q46391592 | ||
| Insulin sensitivity by oral glucose minimal models: validation against clamp | Q46598377 | ||
| Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals | Q46774753 | ||
| Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses | Q46917186 | ||
| Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies | Q46956144 | ||
| Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. | Q51484788 | ||
| Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial. | Q51492013 | ||
| Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. | Q51551670 | ||
| Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. | Q51558724 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. | Q51561681 | ||
| Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. | Q51596078 | ||
| Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. | Q51598262 | ||
| Population approaches to estimate minimal model indexes of insulin sensitivity and glucose effectiveness using full and reduced sampling schedules. | Q51933971 | ||
| Fitting straight lines when both variables are subject to error | Q52795595 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glycobiology | Q899224 |
| preproinsulin | Q7240673 | ||
| glucose | Q37525 | ||
| P304 | page(s) | 1901-1907 | |
| P577 | publication date | 2008-06-12 | |
| P1433 | published in | Obesity | Q15763232 |
| P1476 | title | Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test | |
| P478 | volume | 16 |
| Q34392359 | Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adults |
| Q33585867 | Age-dependent decline in β-cell function assessed by an oral glucose tolerance test-based disposition index |
| Q51300217 | An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome. |
| Q44291220 | An explained variance-based genetic risk score associated with gestational diabetes antecedent and with progression to pre-diabetes and type 2 diabetes: a cohort study |
| Q35756182 | Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus |
| Q47564766 | Assessment of disturbed glucose metabolism and surrogate measures of insulin sensitivity in obese children and adolescents |
| Q47422287 | Association between metabolic deteriorations and prior gestational diabetes according to weight status |
| Q90982691 | Association of changes in inflammation with variation in glycaemia, insulin resistance and secretion based on the KORA study |
| Q51367547 | Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. |
| Q36281320 | Associations of lipid profiles with insulin resistance and β cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation |
| Q57464189 | Associations of sleep duration and quality with serum and hepatic lipids: The Netherlands Epidemiology of Obesity Study |
| Q42905306 | Beta cell dysfunction and its clinical significance in gestational diabetes |
| Q34016062 | Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy |
| Q44418043 | Breakfast and exercise contingently affect postprandial metabolism and energy balance in physically active males |
| Q37163530 | Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men |
| Q35060137 | Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance |
| Q53696333 | Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats. |
| Q87299276 | Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan in the ERA JUMP study: was the calculation of disposition index legitimate? |
| Q42414928 | Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan in the ERA JUMP study: was the calculation of disposition index legitimate? Reply to Yamauchi K, Sato Y, Nakasone Y et al [letter]. |
| Q45777529 | Comparison of oral and intravenous glucose tolerance test derived sensitivity and secretory indices in obese adolescents |
| Q51366807 | Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. |
| Q42455184 | Correlations between A1c, fasting glucose, 2h postload glucose, and β-cell function in the Chinese population |
| Q35578244 | Dapagliflozin lowers plasma glucose concentration and improves β-cell function |
| Q46875772 | Declining ß-cell function is associated with the lack of long-range negative correlation in glucose dynamics and increased glycemic variability: A retrospective analysis in patients with type 2 diabetes |
| Q82307061 | Delayed ghrelin suppression following oral glucose tolerance test in children and adolescents with hypothalamic injury secondary to craniopharyngioma compared with obese controls |
| Q51306632 | Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time: insight from the first year postpartum. |
| Q91710306 | Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort |
| Q42446656 | Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes |
| Q34439570 | Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test. |
| Q41055915 | Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status. |
| Q38165184 | Diabetes and beta cell function: from mechanisms to evaluation and clinical implications |
| Q53765904 | Differences in Anthropometric and Metabolic Parameters Between Subjects with Hypoglycaemia and Subjects with Euglycaemia After an Oral Glucose Tolerance Test Six Months After Laparoscopic Sleeve Gastrectomy. |
| Q40433596 | Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study |
| Q37022686 | Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes |
| Q36305369 | Early impaired β-cell function in chinese women with polycystic ovary syndrome |
| Q53074001 | Ectopic fat in youth: the contribution of hepatic and pancreatic fat to metabolic disturbances. |
| Q51365716 | Effects of brief perturbations in energy balance on indices of glucose homeostasis in healthy lean men. |
| Q42859119 | Effects of genetic severity on glucose homeostasis in Friedreich ataxia |
| Q47901949 | Effects of immediate-release niacin and dietary fatty acids on acute insulin and lipid status in individuals with metabolic syndrome. |
| Q90664827 | Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism |
| Q43225411 | Evaluation of proposed oral disposition index measures in relation to the actual disposition index |
| Q37106554 | Evidence of reduced β-cell function in Asian Indians with mild dysglycemia |
| Q34319297 | Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion |
| Q45881876 | Fasting capillary glucose as a screening test for ruling out gestational diabetes mellitus |
| Q35360690 | GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification |
| Q35856775 | Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans |
| Q51360890 | Glycated hemoglobin in pregnancies at increased risk for gestational diabetes mellitus. |
| Q45158085 | Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels |
| Q36088149 | Glycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus |
| Q37056930 | Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance |
| Q58757738 | Hepatic fat and glucose tolerance in women with recent gestational diabetes |
| Q36560217 | High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D |
| Q51131071 | High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents. |
| Q49336084 | Higher Ratio of Abdominal Subcutaneous to Visceral Adipose Tissue Related with Preservation of Islet β-Cell Function in Healthy Individuals. |
| Q54959936 | Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study. |
| Q38734509 | Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus |
| Q92894608 | Impact of a High Intake of Dairy Product on Insulin Sensitivity in Hyperinsulinemic Adults: A Crossover Randomized Controlled Trial |
| Q47269973 | Impact of glycaemic index and dietary fibre on insulin sensitivity during the refeeding phase of a weight cycle in young healthy men. |
| Q47266074 | Impact of weight loss-associated changes in detailed body composition as assessed by whole-body MRI on plasma insulin levels and homeostatis model assessment index. |
| Q51373546 | Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. |
| Q37223610 | Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose |
| Q42477903 | Initial short‐term intensive insulin therapy as a strategy for evaluating the preservation of beta‐cell function with oral antidiabetic medications: a pilot study with sitagliptin |
| Q36080960 | Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study |
| Q40567389 | Insulin sensitivity and β-cell function in normoglycemic offspring of individuals with type 2 diabetes mellitus: Impact of line of inheritance |
| Q53826099 | Insulin sensitivity assessed using urine C peptide creatinine ratio (UCPCR) in pregnancy: cross-sectional analysis of an English multiethnic cohort. |
| Q37576401 | Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus |
| Q37660926 | Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission |
| Q90392713 | Long-term increase of insulin secretion in mice subjected to pregnancy and lactation |
| Q36538797 | Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study |
| Q42982910 | Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study |
| Q36868232 | Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus |
| Q36868359 | Measuring β-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice? |
| Q50065371 | Metabolic Clusters and Outcomes in Older Adults: The Cardiovascular Health Study |
| Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
| Q89986325 | Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity |
| Q89127326 | Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT) |
| Q34006475 | Moderate diet-induced weight loss is associated with improved insulin sensitivity in middle-aged healthy obese Korean women |
| Q89837573 | Neighborhood walkability and risk of gestational diabetes |
| Q36987281 | Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function |
| Q41613032 | OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus |
| Q51386048 | Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. |
| Q38408520 | One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study |
| Q43503494 | Only minor additional metabolic health benefits of high as opposed to moderate dose physical exercise in young, moderately overweight men. |
| Q36004565 | Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index |
| Q37067149 | Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels |
| Q36782837 | Performance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography |
| Q36314713 | Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans |
| Q51361373 | Plasma testosterone in adult normoglycaemic men: impact of hyperinsulinaemia. |
| Q58876504 | Prediabetes in youth - mechanisms and biomarkers |
| Q58761854 | Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks' Gestation |
| Q39468025 | Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes |
| Q35973869 | Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass |
| Q36311249 | Preventing diabetes in obese Latino youth with prediabetes: a study protocol for a randomized controlled trial |
| Q38783198 | Prior lactation reduces future diabetic risk through sustained postweaning effects on insulin sensitivity |
| Q92544110 | Prolonged plasma glucose elevation on oral glucose tolerance test in young healthy Japanese individuals |
| Q88017549 | Prospective associations of dietary carbohydrate, fat, and protein intake with β-cell function in the CODAM study |
| Q35405441 | Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study |
| Q41075444 | Relationship Between β-cell Response and Insulin Sensitivity in Horses based on the Oral Sugar Test and the Euglycemic Hyperinsulinemic Clamp |
| Q37014274 | Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic |
| Q51370258 | Relationships between fetal growth and maternal body mass indices, plasma glucose level, and plasma insulin level in Japanese women with mildly impaired glucose tolerance. |
| Q42873700 | Repeatability of Indices of Insulin Sensitivity and Secretion from Standard Liquid Meal Tests in Subjects with Type 2 Diabetes Mellitus or Normal or Impaired Fasting Glucose |
| Q37346162 | Resistance training improves indices of muscle insulin sensitivity and β-cell function in overweight/obese, sedentary young men. |
| Q39298394 | Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium |
| Q35895869 | Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus |
| Q36126343 | Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes. |
| Q90402106 | Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients |
| Q42966193 | Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT. |
| Q37163695 | Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty. |
| Q51361908 | Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes. |
| Q51049617 | Sugar-sweetened product consumption alters glucose homeostasis compared with dairy product consumption in men and women at risk of type 2 diabetes mellitus. |
| Q90381152 | The Association between Adult Weight Gain and Insulin Resistance at Middle Age: Mediation by Visceral Fat and Liver Fat |
| Q92082477 | The Association between Habitual Sleep Duration and Sleep Quality with Glycemic Traits: Assessment by Cross-Sectional and Mendelian Randomization Analyses |
| Q35544013 | The Insulin Resistance but Not the Insulin Secretion Parameters Have Changed in the Korean Population during the Last Decade. |
| Q33757756 | The association between serum uric acid and residual β -cell function in type 2 diabetes |
| Q38016319 | The disposition index: from individual to population approach |
| Q33910536 | The effect of high-intensity breastfeeding on postpartum glucose tolerance in women with recent gestational diabetes |
| Q42849210 | The insulin secretion-sensitivity index-2 (ISSI-2) and the measurement of beta-cell function in women with gestational diabetes |
| Q41452010 | The oral disposition index is a strong predictor of incident diabetes in Asian Indian prediabetic men. |
| Q35109649 | The relationship between serum 25-hydroxy vitamin D and insulin sensitivity and β-cell function in newly diagnosed type 2 diabetes. |
| Q35780867 | The role of adipokines in gestational diabetes mellitus |
| Q98613096 | Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes |
| Q50569941 | Urinary markers of nucleic acid oxidation in Danish overweight/obese children and youths. |
| Q51329417 | White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals--the PROMISE cohort. |
Search more.